EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Beyond a Conduit: The Evolution of Functional Biliary Stents From Active Intervention to Enabling Platforms

Muhan Li, Xu Liu, Xin Ye, Zhixia Dong, Xinjian Wan

iNew Medicine · 2025

DOI: 10.1002/inm3.70009 ↗
AbstractBibliografische Angaben

Abstract

ABSTRACT Biliary stenting is the primary minimally invasive therapy for biliary strictures. However, the long‐term patency of conventional plastic and self‐expandable metal stents is limited by two principal failure modes: tissue‐proliferative restenosis and nonproliferative luminal occlusion. In response to these challenges, the design of functional biliary stents has evolved significantly, marking a paradigm shift from direct “active intervention” against failure mechanisms to the development of integrative “enabling platforms.” This review systematically outlines this technological and philosophical progression. Initial “active intervention” strategies are detailed, which were designed to directly counteract stent failure. These include stents engineered to inhibit tissue proliferation through the elution of chemotherapeutic agents or the incorporation of radioactive seeds for brachytherapy. Concurrently, to prevent luminal occlusion, designs have focused on mitigating duodenal reflux, modifying surface materials to inhibit biofilm formation, and modulating the biliary microenvironment. Subsequently, the review examines the transition toward next‐generation “enabling platforms,” which leverage novel materials and advanced manufacturing. Key innovations in this domain include (1) biodegradable polymer and metal‐based stents that obviate the need for subsequent removal; (2) 3D and 4D printing technologies for fabricating patient‐specific, geometrically complex, and dynamically responsive devices; (3) tissue‐engineered stents that serve as scaffolds to guide autologous bile duct regeneration; and (4) “smart” stents integrated with sensors for real‐time monitoring of patency and the local environment. The future trajectory of biliary stent technology is toward highly integrated, personalized “theranostic” systems. These platforms will likely combine biodegradability with multimodal functionalities, including targeted drug delivery, diagnostics, and regenerative capabilities. The ultimate objective is to transform biliary stenting from a palliative, foreign body implantation into a durable, physiological reconstruction of the bile duct.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →